Drug Profile
Research programme: TAPET vector protein delivery systems - Vion Pharmaceuticals
Alternative Names: TAPET-CD; VNP 25; VNP 69Latest Information Update: 08 Jan 2010
Price :
$50
*
At a glance
- Originator Vion Pharmaceuticals; Yale University
- Class Bacteria; Radiopharmaceutical diagnostics
- Mechanism of Action Radionuclide imaging enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Suspended Cancer
Most Recent Events
- 17 Dec 2009 Tapet vector technology is available for licensing (http://www.vionpharm.com)
- 10 May 2005 Tapet vector technology is available for licensing in the US (www.vionpharm.com)
- 01 Oct 2004 Suspended - Preclinical for Cancer diagnosis in USA (unspecified route)